Scope: |
This ESSENTIAL describes the regulatory requirements of In-Vitro Diagnostic devices in Japan, based on the
- Act on Pharmaceuticals and Medical Devices" (PMD Act)
- MHLW and PMDA documents/guides
In-Vitro-Diagnostics are regulated under the "Pharmaceuticals and Medical Devices" Acts.
The main information is provided in: Regulatory ESSENTIAL JPN Medical Devices. This ESSENTIAL lists the IVD specific information only.
|
Legislation in force: |
Short name: Act on Pharmaceuticals and Medical Devices" (PMD Act)
Content (Excerpt):
Chapter V Marketing and Manufacturing Businesses for Medical Devices and In-vitro Diagnostics
Section 1 Marketing and Manufacturing of Medical Devices and In-vitro Diagnostics (Articles 23-2 to 23-2-22)
Section 2 Registered Certification Bodies (Articles 23-2-23 to 23-19)
Chapter IX Handling of Pharmaceuticals, etc.
Section 5 Handling of Medical Devices(Articles 63 to 65)
Chapter XIII Supervision
Article 69 - On-Site Inspections
Chapter XVII Penalties (Articles 83-6 to 91)
IVD Definition (Article 2)
(14) The term "in-vitro diagnostic" as used in this Act refers to pharmaceuticals intended exclusively for use in the diagnosis of diseases, which are not directly used in the bodies of humans or animals.
|